Mh 701 - Study guides, Class notes & Summaries

Looking for the best study guides, study notes and summaries about Mh 701? On this page you'll find 133 study documents about Mh 701.

Page 3 out of 133 results

Sort by

MH 701 SAFETY EXAM #2 Summer 20- Questions and Answers
  • MH 701 SAFETY EXAM #2 Summer 20- Questions and Answers

  • Exam (elaborations) • 10 pages • 2024
  • MH 701 SAFETY EXAM #2 Summer 20
    (0)
  • $11.49
  • + learn more
MH 701 exam 1 with correct answers 2024
  • MH 701 exam 1 with correct answers 2024

  • Exam (elaborations) • 21 pages • 2024
  • MH 701 exam 1
    (0)
  • $10.99
  • + learn more
MH 701 Exam 3 Questions and Answers Latest Updated 2023/2024 Graded 100%
  • MH 701 Exam 3 Questions and Answers Latest Updated 2023/2024 Graded 100%

  • Exam (elaborations) • 34 pages • 2023
  • MH 701 Exam 3 Questions and Answers Latest Updated 2023/2024 Graded 100%. What is the neurotranmitter involved with addiction? All drugs that can lead to addiction increase dopamine (DA) in ventral striatum, also called the nucleus accumbens. 4. Psychological dependence Characterized by a continuous or intermittent craving (i.e., intense desire) for the substance to avoid a dysphoric state. 5. physical dependence A type of addiction in which the body itself feels a direct need for a dr...
    (0)
  • $15.49
  • + learn more
Exam 2: MH701/ MH 701 (Latest 2023/ 2024 Update) Psychopharmacologic/Neuroscience Foundations of Mental Health Care Exam Review| Questions and Verified Answers| 100% Correct- FNU
  • Exam 2: MH701/ MH 701 (Latest 2023/ 2024 Update) Psychopharmacologic/Neuroscience Foundations of Mental Health Care Exam Review| Questions and Verified Answers| 100% Correct- FNU

  • Exam (elaborations) • 56 pages • 2023
  • Exam 2: MH701/ MH 701 (Latest 2023/ 2024 Update) Psychopharmacologic/Neuroscience Foundations of Mental Health Care Exam Review| Questions and Verified Answers| 100% Correct- FNU Q: Goals of pharmacological treatment for mood disorders: Answer: 1. Should be directed toward several goals. First, the patient's safety must be guaranteed. 2. a complete diagnostic evaluation of the patient is necessary. 3. A treatment plan that addresses not only the immediate symptoms but also the patien...
    (0)
  • $11.49
  • + learn more
MH 701: Quiz 2, Module 4, Mood Stabilizers Questions and answers with 100% correct solutions | A+ Grade
  • MH 701: Quiz 2, Module 4, Mood Stabilizers Questions and answers with 100% correct solutions | A+ Grade

  • Exam (elaborations) • 20 pages • 2024
  • Which disorder has at least one full manic episode, lasting at least one week? Hypomanic or depressive episodes may also occur but are not required for diagnosis. Bipolar 1 disorder What is DIGFAST? A mnemonic for the signs of mania: Distractibility Impulsivity/Indiscretion Grandiosity Flight of ideas Activity increase Sleep decrease Talkativeness How many DSM V criteria for mania must be present to diagnose a manic episode? Three or more How long must symptoms be present to diagnose...
    (0)
  • $8.99
  • + learn more
MH 701 exam 1 questions and answers / graded a
  • MH 701 exam 1 questions and answers / graded a

  • Exam (elaborations) • 21 pages • 2024
  • MH 701 exam 1
    (0)
  • $10.49
  • + learn more
MH 701 SAFETY EXAM #2 Summer 20 Exam Questions And Answers MH 701 SAFETY EXAM #2 Summer 20 Exam Questions And Answers
  • MH 701 SAFETY EXAM #2 Summer 20 Exam Questions And Answers MH 701 SAFETY EXAM #2 Summer 20 Exam Questions And Answers

  • Exam (elaborations) • 10 pages • 2023
  • Available in package deal
  • MH 701 SAFETY EXAM #2 Summer 20 Exam Questions And Answers What differentiates SGAs from FGAs? - ANS SGAs have: D2 and 5HT2A receptor antagonism + Antidepressant action, treat pos and neg schizo sx, metabolic SE, D2D interactions, approved for schizophrenia, mania, and acute mania FGAs have positive symptom antipsychotic actions - EPS, hyperprolactinemia Mostly D2 receptor antagonism Which SGA has lowest EPS SE, but is associated with substantial risk of agranulocytosis? - ANS ...
    (0)
  • $11.49
  • + learn more
MH 701 Safety Exam #1 Study Guide
  • MH 701 Safety Exam #1 Study Guide

  • Exam (elaborations) • 8 pages • 2023
  • 1. T/F - Both genetic and environmental factors influence individual response to, and tolerability of, psychotropic agents. - Answer- True 2. T/F - FDA approved psychotropics are similar in overall effectiveness for their indicated disorder. - Answer- True 3. The dopamine systems highly relevant to psychiatry include: - Answer- a. Nigrostriatal i. Degeneration leads to Parkinson's ii. Drugs that inhibit dopamine here cause EPS b. Mesocorticolimbic- i. Reward pathway (addiction) ii....
    (0)
  • $11.49
  • + learn more
MH 701 SAFETY EXAM #2 Questions With 100% Correct Solutions.
  • MH 701 SAFETY EXAM #2 Questions With 100% Correct Solutions.

  • Exam (elaborations) • 13 pages • 2024
  • Available in package deal
  • What differentiates SGAs from FGAs? - SGAs have: D2 and 5HT2A receptor antagonism + Antidepressant action, treat pos and neg schizo sx, metabolic SE, D2D interactions, approved for schizophrenia, mania, and acute mania FGAs have positive symptom antipsychotic actions - EPS, hyperprolactinemia Mostly D2 receptor antagonism Which SGA has lowest EPS SE, but is associated with substantial risk of agranuloycytosis? - Clozapine The lower D2 receptor action is probably why clozapine does not c...
    (0)
  • $7.19
  • + learn more
MH 701 Safety Exam #1 Study Guide Questions and answers with 100% correct solutions | A+ Grade
  • MH 701 Safety Exam #1 Study Guide Questions and answers with 100% correct solutions | A+ Grade

  • Exam (elaborations) • 13 pages • 2024
  • 1. T/F - Both genetic and environmental factors influence individual response to, and tolerability of, psychotropic agents. True 2. T/F - FDA approved psychotropics are similar in overall effectiveness for their indicated disorder. True 3. The dopamine systems highly relevant to psychiatry include: a. Nigrostriatal i. Degeneration leads to Parkinson's ii. Drugs that inhibit dopamine here cause EPS b. Mesocorticolimbici. Reward pathway (addiction) ii. Target of antipsychotic properties (...
    (0)
  • $8.99
  • + learn more